Read on Twitter
PHARMA: When we have an ‘outbreak’ of something there are usually one or two companies that lead and develop supposedly preventative vaccines. This time round we have every Pharma company under the sun making what are not typical vaccines or treatments. DJT spent a lot of time
highlighting these companies, one by one in his press conferences. First we have Pfizer/BioNTech with a novel mRNA ‘vaccine’ which seems to have significant side effects if VAERS reports are to be believed. Then Moderna, another novel mRNA (VAERS also showing high reaction rate),
DJT considered fast tracking AstraZeneca vaccine with its Monkey adenovirus altered spike protein in GMO human foetal kidney cell lines, but instead Pfizer pipped them to the post. https://nypost.com/2020/08/24/trump-considers-fast-tracking-astrazeneca-vaccine-before-election-report/ Then we have the company Eli Lili with its regeneron monoclonal antibody.
After DJT ‘left office’ and handed over to Pres Biden, we then have two more companies step up, Johnson & Johnson whose stock price plummets on its only 65% effectiveness... though the reports of many care homes patients being wiped out by Covid after the Pfizer or AZ vaccine...
does not exactly back their 95% up. Then we have Novavax, who are taking a recombinant spike protein approach similarly to AstraZeneca. https://www.verywellhealth.com/novavax-covid-19-vaccine-5093292 Check out its glowing stock market report. https://www.msn.com/en-us/money/markets/why-novavax-could-be-a-bigger-covid-vaccine-winner-than-pfizer-and-moderna/ar-BB1bunvY
Here is what AstraZeneca and Johnson & Johnson shares are doing. 5 day not 6 month chart for J&J to illustrate what happens when your ‘vaccine’ is not up to perceived scratch
Then we have Novavax Stock price which has shot through the roof since it’s announcement in the UK and US as 89.3% effective, effective for what exactly? Last on this part of the thread we have Eli Lili, whose share price seems to have also shot through the roof...
in the abscence of any particularly bad news. I cannot get away from the feeling that these companies are connected in some way, apart from them all obviously being Pharma. There are so many horses in the race with completely novel treatments for something that seems, judging...
by the raft of care home deaths, untreatable. So why are they in this race? For the kudos, the money? Can anyone find a link between these firms other than the obvious?
